共 19 条
- [11] O'Dea J.P.K., Davis E.H., Tamoxifen in the treatment of menstrual migraine, Neurology, 40, pp. 1470-1471, (1990)
- [12] Olesen J., Bes A., Kunkel R., Et al., Classification and diagnostic criteria for headache disorders, cranial neuralgias and facial pain, 1st edn, Cephalagia, 8, 7 SUPPL., pp. 19-28, (1988)
- [13] Ophoff R.A., Terwindt G.M., Vergouve M.N., Et al., Familial hemiplegic migraine and episodic ataxia type-2 are caused by the mutations in the Ca <sup>2+</sup> channel gene CACNL 1A4, Cell, 87, pp. 543-552, (1996)
- [14] Silberstein S.D., The role of sex hormones in headache, Neurology, 42, 2 SUPPL., pp. 37-42, (1992)
- [15] Silberstein S.D., Massiou H., Le Jeunne C., Et al., Rizatriptan in the treatment of menstrual migraine, Obstet Gynecol, 96, pp. 237-242, (2000)
- [16] Sommerville B.W., The role of estradiol withdrawal in the etiology of menstrual migraine, Neurology, 22, pp. 355-365, (1972)
- [17] Sommerville B.W., Estrogen-withdrawal migraine I. Duration of exposure required and attempted prophylaxis by premenstrual estrogen administration, Neurology, 25, pp. 239-244, (1975)
- [18] Sommerville B.W., Estrogen-withdrawal migraine II. Attempted prophylaxis by continuous estradiol administration, Neurology, 25, pp. 245-250, (1975)
- [19] Weiller C., May A., Limmroth V., Et al., Brain stem activation in spontaneous human migraine attacks, Nature Med, 1, pp. 658-660, (1995)